Understanding Recovery After Pulmonary Embolism – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn about a recent article by Simon Wolf et al, published in JTH, adding:
“DYK:
Up to 50 percent of patients with pulmonary embolism (PE) may experience some degree of long term functional impairment, with symptoms including shortness of breath, reduced exercise tolerance and deconditioning that can persist for months or even years.
Post PE syndrome can also extend beyond physical symptoms.
Depression, anxiety and other psychosocial complications may significantly affect quality of life following PE.
A new Journal of Thrombosis and Haemostasis (JTH) in Clinic review examines what we currently know about recovery after acute PE, including:
- The course of recovery following PE
- Determinants associated with poor long term outcomes
- Persistent changes in pulmonary and cardiac function
- Physical and psychosocial components of post PE syndrome
- Potential interventions to improve recovery and quality of life
While awareness of post PE complications has grown, important questions remain about why symptoms persist and how they can best be prevented and managed.
Explore the full review in JTH.”
Title: Long-term course and recovery following pulmonary embolism
Authors: Simon Wolf, Sophie N.M. ter Haar, Caoimhe Kenny, Stefano Barco, Thijs E. van Mens, Frederikus A. Klok
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters
-
Sep 26, 2026, 15:30P-Selectin as a Therapeutic Target in Thrombosis
-
Sep 26, 2026, 15:27Berkan Kurt: The Role of Biomarkers in Cardiovascular Prevention
-
Sep 26, 2026, 15:21Consuela A. Albright: Five Concrete Ways Steps to Advocate for Sickle Cell Disease